Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

Organigram Global Inc.NASDAQ: OGI

Common Stock · Q2 FY2026 · quarter ended Mar 2026

Common stock broadly unchanged from a year ago

Common stock stood at CA$926.57M at the end of Q2 FY2026, up 1.0% from a year earlier and up 0.6% from the prior quarter.

Context

  • Common stock amounted to 177.3% of total assets at the end of Q2 FY2026, up 6.8 pp from a year earlier.
  • Common stock increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether common stock keeps rising in the next quarterly balance sheet after a +1.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$926.57M+0.6% QoQ
Last fiscal yearSep 2025
CA$919.91M+7.9% YoY
Year agoMar 2025
CA$917.28M+1.0% since
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.0%——
1 year+7.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock history

CAD · from the balance sheet

Latest · FY2025
919.91M CAD
Year-over-year change
+7.9%
4-year CAGR
+5.9%

Common Stock vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +1.0% is the 6th highest of 9, against a peer median of +25.5%.
  • Common stock amounts to 177.3% of total assets for OGI, versus a peer median of 0.0%.
OGI Competitors
Common Stock for OGI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ACBAurora Cannabis Inc.Mar 2026CA$7.03B CAD+1.1%+0.9%1165.8%
OGIOrganigram Global Inc.Mar 2026CA$926.57M CAD+1.0%—177.3%
IVAInventiva S.A.Dec 2025€1.93M EUR+101.8%+66.2%0.8%
ELMDElectromed, Inc.Mar 2026$83K USD-2.4%-0.8%0.1%
HSDTSolana CompanyMar 2026$57K USD+850.0%+16.3%0.0%
LFCRLifecore Biomedical, Inc.Dec 2025$37K USD——0.0%
OBIOOrchestra BioMed Holdings, Inc.Mar 2026$6K USD+50.0%+44.2%0.0%
RNACCartesian Therapeutics, Inc.Mar 2026$3K USD+0.0%-41.5%0.0%
DERMJourney Medical CorporationMar 2026$3K USD+50.0%+0.0%0.0%
INFUInfuSystem Holdings, Inc.Mar 2026$2K USD+0.0%+0.0%0.0%
Peer median (excluding OGI) —+25.5%+0.4%0.0%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents55.37M68.52M33.86M106.75M28.2M
Short-term Investments128.48M30.4M0821K826K
Net Receivables21M46.37M27.46M37.15M64.86M
Inventory48.82M68.28M80.95M82.52M123.95M
Other Current Assets5.51M2.21M13.7M25.86M55.39M
Total Current Assets260.62M221.62M155.98M262.22M284.9M
Property, Plant & Equipment (Net)235.94M259.82M99.05M96.23M122.98M
Goodwill14.32M41.98M0052.52M
Intangible Assets2.73M14.26M10.62M8.09M48.51M
Long-term Investments6.11M7.07M13.72M40.73M49.55M
Tax Assets3.2M0000
Other Non-current Assets31.11M32.36M19.09M591K3.75M
Total Non-current Assets293.4M355.48M142.48M145.64M277.31M
Total Assets554.02M577.11M298.46M407.86M562.21M
Account Payables18.95M40.86M14.73M47.1M89.25M
Short-term Debt80K80K76K60K25K
Tax Payables01.42M94K00
Deferred Revenue02.44M000
Other Current Liabilities6.25M12M2.35M5.14M35.91M
Total Current Liabilities26.27M55.29M22.43M53.32M126.16M
Long-term Debt230K155K3.63M25K0
Deferred Tax Liabilities03.62M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities43.07M7.79M771K45.18M79.17M
Total Non-current Liabilities47.95M13.76M4.4M48.55M86.92M
Total Liabilities74.21M69.05M26.83M101.87M213.08M
Common Stock730.8M769.73M776.91M852.89M919.91M
Retained Earnings(275.64M)(289.93M)(538.53M)(583.97M)(608.73M)
Accumulated OCI24.65M28.26M33.25M37.07M37.95M
Other Stockholders Equity00000
Minority Interest00000
Total Equity479.81M508.06M271.62M305.99M349.13M
Total Debt5.95M3.36M3.71M4.46M8.75M
Net Debt(49.42M)(65.16M)(30.16M)(102.29M)(19.45M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.